|
ZC3H14 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.93200000001104E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.955390E-04 |
| Normal-vs-Stage2 |
1.289800E-02 |
| Normal-vs-Stage3 |
3.62910000051286E-07 |
| Normal-vs-Stage4 |
2.47379999818165E-08 |
| Stage1-vs-Stage2 |
5.797800E-01 |
| Stage1-vs-Stage3 |
2.333900E-02 |
| Stage1-vs-Stage4 |
1.677490E-03 |
| Stage2-vs-Stage3 |
4.121600E-02 |
| Stage2-vs-Stage4 |
6.561200E-03 |
| Stage3-vs-Stage4 |
3.704800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.95559999994455E-07 |
| Normal-vs-AfricanAmerican |
2.454100E-02 |
| Normal-vs-Asian |
6.031500E-04 |
| Caucasian-vs-AfricanAmerican |
4.470800E-01 |
| Caucasian-vs-Asian |
4.585000E-01 |
| AfricanAmerican-vs-Asian |
7.977000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.22970000004941E-06 |
| Normal-vs-Female |
3.54639999999851E-05 |
| Male-vs-Female |
2.887200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.636760E-04 |
| Normal-vs-Age(41-60Yrs) |
7.76319999999942E-05 |
| Normal-vs-Age(61-80Yrs) |
7.97080000003447E-07 |
| Normal-vs-Age(81-100Yrs) |
1.123420E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.777000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.845240E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.191600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.980200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.358200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.261600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.031970E-04 |
| Classical-VS-Follicular |
4.314200E-01 |
| Classical-VS-Other |
9.737000E-01 |
| Classical-VS-Normal |
3.60200000000255E-05 |
| Tall-VS-Follicular |
2.200200E-04 |
| Tall-VS-Other |
6.952100E-02 |
| Tall-VS-Normal |
3.75940001351438E-09 |
| Follicular-VS-Other |
8.263000E-01 |
| Follicular-VS-Normal |
1.241980E-02 |
| Other-VS-Normal |
1.228760E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.753680E-04 |
| Normal-vs-N1 |
1.80080000000693E-06 |
| N0-vs-N1 |
8.699800E-02 |
|
|
